TORASEMIDE IN COMPARISON WITH THIAZIDES IN THE TREATMENT OF HYPERTENSION

被引:27
作者
BAUMGART, P [1 ]
机构
[1] CLEMENSHOSP,DEPT INTERNAL MED 1,W-4400 MUNSTER,GERMANY
关键词
HYPERTENSION; TORASEMIDE; THIAZIDES; METABOLIC SIDE EFFECTS; CIRCADIAN RHYTHM;
D O I
10.1007/BF00877959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are a number of clinically relevant differences between torasemide and the thiazide diuretics in the treatment of hypertension. Only 2.5-5 mg torasemide once daily is sufficient for antihypertensive treatment; these low doses of torasemide exert comparable antihypertensive effects to those of the overtly natriuretic doses of thiazides (e.g., hydrochlorothiazide 25 mg) that are currently used once daily for the treatment of hypertension. Whereas natriuretic thiazide doses reduce blood pressure rapidly, the blood pressure-lowering effect of low-dose torasemide appears to occur more gradually during the first weeks of treatment. The diurnal blood pressure rhythm is not altered by either drug. In contrast to the thiazides, torasemide does not cause significant renal potassium loss in doses recommended to treat hypertension. Long-term antihypertensive treatment with torasemide has not resulted in undesired metabolic side effects, such as hypomagnesemia, alterations in glucose and lipid metabolism, or hyperuricemia. As compared with the thiazides, torasemide appears to be a safer and equally effective alternative for antihypertensive treatment when subdiuretic doses of this loop diuretic are used.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 30 条
[1]  
Achhammer I, 1991, Drugs, V41 Suppl 3, P80
[2]  
ACHHAMMER I, 1990, PR PHARM CL, V8, P211
[3]   THE INFLUENCE OF NON-BETA-BLOCKING DRUGS ON THE LIPID PROFILE - ARE DIURETICS OUTCLASSED AS INITIAL THERAPY FOR HYPERTENSION [J].
AMES, RP .
AMERICAN HEART JOURNAL, 1987, 114 (04) :998-1006
[4]  
BAUMGART P, 1990, PR PHARM CL, V8, P169
[5]  
Boelke T, 1990, HOCHDRUCK, V10, P40
[6]  
Boelke T, 1990, HOCHDRUCK, V9, P40
[7]   RELATION BETWEEN DOSE OF BENDROFLUAZIDE, ANTIHYPERTENSIVE EFFECT, AND ADVERSE BIOCHEMICAL EFFECTS [J].
CARLSEN, JE ;
KOBER, L ;
TORPPEDERSEN, C ;
JOHANSEN, P .
BRITISH MEDICAL JOURNAL, 1990, 300 (6730) :975-978
[8]  
CARRAGETA O, 1983, CLIN NEPHROL S1, V19, P114
[9]  
DUPONT AG, 1988, J HUM HYPERTENS, V2, P265
[10]   EFFECTS OF REDUCTION IN DRUGS OR DOSAGE AFTER LONG-TERM CONTROL OF SYSTEMIC HYPERTENSION [J].
FREIS, ED ;
THOMAS, JR ;
FISHER, SG ;
HAMBURGER, R ;
BORRESON, RE ;
MEZEY, KC ;
MUKHERJI, B ;
NEAL, WW ;
PERRY, HM ;
TAGUCHI, JT .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (11) :702-708